ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,390Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 2094

$1.14M Total Retail Price of All Prescriptions

Rank: 63 out of 2094

606 Patients Receiving at Least One Drug in Part D
41%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 6,771 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LOVAZA 493 215 1 53
SIMVASTATIN 394 227 2 1
METFORMIN HCL 371 185 3 8
AMLODIPINE BESYLATE 352 181 4 2
OMEPRAZOLE 345 155 5 4
ATORVASTATIN CALCIUM 330 147 6 5
PROAIR HFA 284 101 7 45
LISINOPRIL 268 85 8 7
ENALAPRIL MALEATE 263 118 9 25
FUROSEMIDE 241 92 10 6
ZOLPIDEM TARTRATE 226 123 11 14
IBUPROFEN 223 38 12 73
GABAPENTIN 214 98 13 23
DIOVAN HCT 209 124 14 28
METOPROLOL TARTRATE 208 86 15 10
TRAMADOL HCL 207 62 16 33
CYCLOBENZAPRINE HCL 197 61 R 17 115
HYDROCHLOROTHIAZIDE 183 81 18 12
NEXIUM 173 72 19 16
DICLOFENAC SODIUM 169 81 20 168
LEVOTHYROXINE SODIUM 163 91 21 3
METOPROLOL SUCCINATE 150 86 22 9
POTASSIUM CHLORIDE 150 40 22 24
COMBIVENT 149 76 24 211
CARVEDILOL 148 97 25 19
ADVAIR DISKUS 141 48 26 36
CRESTOR 138 63 27 15
GLIMEPIRIDE 132 66 28 31
RANITIDINE HCL 132 95 28 80
FLUTICASONE PROPIONATE 129 42 30 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 64 31 55
WARFARIN SODIUM 122 47 32 11
ACETAMINOPHEN-CODEINE 122 50 S3 32 129
TRAZODONE HCL 121 37 34 72
CLOPIDOGREL 117 56 35 22
PLAVIX 112 77 36 38
JANUVIA 111 69 37 35
PANTOPRAZOLE SODIUM 108 63 38 37
ZETIA 102 37 39 79
SERTRALINE HCL 99 35 40 26
CELEBREX 94 61 41 74
HYDROXYZINE HCL 94 47 R 41 232
CARISOPRODOL 94 0 R 41 253
LYRICA 93 56 44 85
DIOVAN 91 68 45 13
CLONIDINE HCL 89 31 46 62
TAMSULOSIN HCL 85 46 47 29
SOLARAZE 82 42 48 278
LACTULOSE 82 30 48 65
LANTUS SOLOSTAR 82 31 48 76
ACTOS 81 43 51 112
FEXOFENADINE HCL 81 41 51 191
GLIPIZIDE XL 80 66 53 122
AVODART 78 73 54 163
ALENDRONATE SODIUM 78 55 54 30
AZITHROMYCIN 76 21 56 27
DEXILANT 74 42 57 124
LIPITOR 73 32 58 39
NIASPAN 73 21 58 145
NIFEDIPINE ER 70 39 60 96
CYMBALTA 66 11 61 61
VENTOLIN HFA 65 22 62 132
GLIPIZIDE 64 46 63 82
ISOSORBIDE MONONITRATE ER 64 35 63 57
MECLIZINE HCL 62 25 65 103
SINGULAIR 62 18 65 64
MEGESTROL ACETATE 60 39 R 67 174
HYDROCODONE-ACETAMINOPHEN 59 34 S3 68 42
TRAMADOL HCL-ACETAMINOPHEN 59 20 68 100
AMMONIUM LACTATE 59 21 68 185
SPIRIVA 58 22 71 60
QUINAPRIL HCL 58 36 71 123
DONEPEZIL HCL 57 43 73 20
BENICAR 56 42 74 108
PROMETHAZINE HCL 55 17 R 75 184
CIPROFLOXACIN HCL 55 21 75 81
DULERA 55 16 75 349
PREDNISONE 55 34 75 54
LIDODERM 54 36 79 59
NAPROXEN 53 14 80 84
PAROXETINE HCL 53 11 80 77
CLOTRIMAZOLE-BETAMETHASONE 52 13 82 91
ATENOLOL 51 31 83 21
TRIAMTERENE-HCTZ 51 15 83 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.